Spondyloarthritis & psoriatic arthritis

Instrument selection for the ASAS core outcome set for axial spondyloarthritis

Ann Rheum DisPublished Consensus statement: core outcome instrument selection

Methodological detailssystematic literature review, OMERACT filter 2.2, international working group, ASAS voting and endorsement
  • Systematic literature review
  • OMERACT filter 2.2
  • International working group
  • ASAS voting and endorsement

Recommendations

As issued by the authors

  1. 7 instruments mandatory for all trials: ASDAS, Numerical Rate Scale (NRS) PGA of disease activity, NRS total back pain, average NRS of duration and severity of morning stiffness, NRS fatigue, BASFI and ASAS Health Index

  2. 9 additional instruments mandatory for DMARD trials: MRI activity Spondyloarthritis Research Consortium of Canada (SPARCC) sacroiliac joints and SPARCC spine, uveitis, IBD and psoriasis assessed as recommended by ASAS, 44 swollen joint count, MASES, dactylitis count and mSASSS

  3. Imaging outcomes mandatory in at least one trial for a drug tested for DMARD properties

  4. 11 additional instruments endorsed by ASAS, usable in axial spondyloarthritis (axSpA) trials on top of the core instruments

Original publication

Instrument selection for the ASAS core outcome set for axial spondyloarthritis. Ann Rheum Dis. Published 9 June 2022. doi:10.1136/annrheumdis-2022-222747

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.